Early research (Phase 1)Study completedNCT05538949What this trial is testingSafety, Tolerability and Pharmacokinetics of EB-203 Eye Drops in Healthy VolunteersWho this might be right forHealthy EyebioKorea, Inc. 28
Not applicableStudy completedNCT00357578What this trial is testingGenetic Study of Age-Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration National Eye Institute (NEI) 150
Testing effectiveness (Phase 2)WithdrawnNCT00457678What this trial is testingSecond Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by ItselfWho this might be right forAge Related Macular Degeneration Vitreous -Retina- Macula Consultants of New York
Early research (Phase 1)Active Not RecruitingNCT06825858What this trial is testingA Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Chengdu Origen Biotechnology Co., Ltd. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04657289What this trial is testingThe Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)Who this might be right forNeovascular Age-related Macular Degeneration (nAMD) Hoffmann-La Roche 451
Not applicableEnded earlyNCT02625376What this trial is testingResveratrol for Exudative Age-Related Macular DegenerationWho this might be right forAMDAge-related Macular DegenerationChoroidal Neovascularisation Poitiers University Hospital 25
Not applicableEnrolling By InvitationNCT07660640What this trial is testingLong-Term Follow Up of VOY-101 Non-nAMD Extension StudyWho this might be right forAge-Related Macular Degeneration (AMD)Non-Neovascular Age-Related Macular Degeneration Perceive Biotherapeutics, Inc. 88
Not applicableStudy completedNCT00342251What this trial is testingInvestigating Age-Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration National Eye Institute (NEI) 3,000
Not applicableStudy completedNCT04395859What this trial is testingCollateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic AgentsWho this might be right forAge Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion Fondation Ophtalmologique Adolphe de Rothschild 233
Not applicableStudy completedNCT02464956What this trial is testingProduction of iPSC Derived RPE Cells for Transplantation in AMDWho this might be right forAge Related Macular Degeneration (AMD) Moorfields Eye Hospital NHS Foundation Trust 3
Not applicableStudy completedNCT01542866What this trial is testingA 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)Who this might be right forAge Related Macular Degeneration (AMD) Novartis Pharmaceuticals 160
Very early researchNot Yet RecruitingNCT06888492What this trial is testingTo Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration Guangzhou Jiayin Biotech Ltd 8
Large-scale testing (Phase 3)Study completedNCT05345236What this trial is testingCompare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration Qilu Pharmaceutical Co., Ltd. 366
Early research (Phase 1)Study completedNCT05105607What this trial is testingEvaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy ParticipantsWho this might be right forNeovascular Age-related Macular DegenerationDiabetic Macular Edema Ashvattha Therapeutics, Inc. 16
Early research (Phase 1)Study completedNCT03777332What this trial is testingStudy to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic AtrophyWho this might be right forGeographic Atrophy Apellis Pharmaceuticals, Inc. 19
Not applicableStudy completedNCT00556114What this trial is testingA Pilot Study of Functional Optical Coherence Tomography for Ocular ImagingWho this might be right forGlaucomaDiabetic RetinopathyAge-Related Macular Degeneration+2 more University of California, Irvine 23
Not applicableLooking for participantsNCT07843212What this trial is testingEFFECTS OF SPSIP BLOCK ON PERIOPERATİVE INFLAMMATION AND TLR4 IN BREAST CANCER SURGERYWho this might be right forSerratus Posterior Superior Intercostal Plane Block (SPSIPB)Breast CancerToll-Like Receptors Mucahide Emine Fidancı Kuas 80
Not applicableWithdrawnNCT01731964What this trial is testingStudy of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular DegenerationWho this might be right forAge Related Macular Degeneration VisionCare, Inc.
Not applicableStudy completedNCT06347107What this trial is testingRobotic Subretinal tPA Injection StudyWho this might be right forSubretinal HemorrhageAge-Related Macular Degeneration Universitaire Ziekenhuizen KU Leuven 20
Not applicableNot Yet RecruitingNCT04794907What this trial is testingRetinal Care Data RepositoryWho this might be right forDiabetic RetinopathyAge Related Macular Degeneration Retinal Care Inc. 1,000